Taken together, these data show that the early growth phase of GLI2A-expressing gastric cancers, but not tumor initiation, is dependent on mTOR/S6 signaling, which may promote tumor growth partly by maintaining cells in an undifferentiated, proliferative state. The gene discussed is MTOR; the disease is neoplasm.